Comparative effectiveness and safety of different basal insulins in a real-world setting-Reference-Cited by-同舟云学术

Comparative effectiveness and safety of different basal insulins in a real-world setting

Published:2017-04-03 Issue:8 Volume:19 Page:1116-1126
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Ji Linong¹²,Zhang Puhong²,Zhu Dongshan²,Lu Juming³,Guo Xiaohui⁴,Wu Yangfeng²,Li Xian⁵,Ji Jiachao⁵,Jia Weiping⁶,Yang Wenying⁷,Zou Dajin⁸,Zhou Zhiguang⁹,Gao Yan⁴,Garg Satish K.¹⁰,Pan Changyu³,Weng Jianping¹¹,Paul Sanjoy K.¹²,

Affiliation:

1. Department of Endocrinology and Metabolism; Peking University People's Hospital; Beijing P.R. China

2. Diabetes Research Program; The George Institute for Global Health at Peking University Health Science Center; Beijing P.R. China

3. Department of Endocrinology; The General Hospital of the People's Liberation Army; Beijing P.R. China

4. Department of Endocrinology; Peking University First Hospital; Beijing P.R. China

5. Biostatistics and Economic Evaluation Program; The George Institute for Global Health at Peking University Health Science Center; Beijing P.R. China

6. Department of Endocrinology and Metabolism; Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai P.R. China

7. Department of Endocrinology; China-Japan Friendship Hospital; Beijing P.R. China

8. Department of Endocrinology; The Second Military Medical University; Shanghai P.R. China

9. Department of Endocrinology; Xiangya Second Hospital; Changsha P.R. China

10. Barbara Davis Center for Diabetes; University of Colorado Denver; Aurora Colorado

11. Department of Endocrinology; The Third Affiliated Hospital of Sun Yat-sen University; Guangzhou P.R. China

12. Melbourne EpiCentre; University of Melbourne; Melbourne Australia

Funder

Sanofi-Aventis (Shanghai, China)

Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12920/fullpdf

Reference35 articles.

1. Standards of medical care in diabetes-2015 abridged for primary care providers;American Diabetes Association;Clin Diabetes,2015

2. American Association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary;Garber;Endocr Pract,2013

3. Global guideline for type 2 diabetes;International Diabetes Federation Guideline Development Group;Diabetes Res Clin Pract,2014

4. China guideline for type 2 diabetes [in Chinese];Chinese Diabetes Society;Chin J Diabetes Mellitus,2013

5. Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials;Erpeldinger;BMC Endocr Disord,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of real world data to improve drug coverage decisions in China;BMJ;2023-06-15

2. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update;Endocrine Practice;2022-10

3. Prospektywna ocena skuteczności i bezpieczeństwa insuliny glargine 100 U / ml (Gla-100) u dorosłych chorych na cukrzycę w Polsce: badanie obserwacyjne LARE;Clinical Diabetology;2021-02-22

4. Insulin therapy is a personalized approach to glycemic management in diabetes;Terapevticheskii arkhiv;2020-12-15

5. Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2;Kachestvennaya klinicheskaya praktika;2020-09-27